Stone Pharmaceutical (01093.HK) today (9th) repurchased 6.6 million shares on the stock exchange, with a price per share ranging from 4.43 to 4.47 yuan, involving approximately 29.379 million yuan. Since the share buyback authorization resolution was approved on May 28, the company has repurchased a total of about 0.352 billion shares, accounting for nearly 2.962% of the total issued share capital.